Saga of “Most Favored Nations”
On Wednesday, December 23, 2020, a Maryland Federal District Court Judge issued a TRO blocking the Trump administration’s attempt to institute, pursuant to an administrative rule, a Most Favored Nations approach for dozens of drugs under the Medicare Program. The challenge made to the administrative rule was that it was issued under the “emergency” provisions […]
Pharmaceutical Industry Challenges President Trump’s Executive Order Adopting Most Favored Nation Approach
My December 2, 2020 blog was a discussion of President Trump’s adoption of the Most Favored Nation approach for the pricing of certain drugs in various federal programs. On Friday, the pharmaceutical industry filed suit challenging the decision of the Trump Administration. It will be interesting to see what action, if any, the new President […]
President Trump issues Executive Order adopting Most Favored Nation Approach
In what appears to be one of President Trump’s last official acts, he has issued an Executive Order adopting, for certain purposes, the Most Favored Nation clause approach to the pricing of drugs in the United States. During the campaign, it was the position of President-Elect Biden that we should be negotiating the price with […]